Proteome of human endometrium: Identification of differentially expressed proteins in proliferative and secretory phase endometrium

Proteomics - Clinical Applications

Volumn 4, Issue 1, 2010, Pages 48-59

  Rai, Priyanka ^a   Kota, Venkatesh ^a   Sundaram, Curam Sreenivasacharlu ^a   Deendayal, Mamta ^b   Shivaji, Sisinthy ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b Infertility Institute and Research Centre   (India)

Author keywords

2 DE; Endometrium; Menstrual cycle; Proliferative phase; Secretory phase

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA ACTIN; CARRIER PROTEIN; CHAPERONE; CHAPERONIN; COLLAGEN TYPE 6; CYTOKERATIN 8; DYNACTIN; F ACTIN; FIBRINOGEN; GELSOLIN; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; LAMIN B; LUNG RESISTANCE PROTEIN; NUCLEOPHOSMIN; PROTEIN 14 3 3; PROTEIN P57; RAB11 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RNA; STRUCTURAL PROTEIN; VIMENTIN; VINCULIN;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENSTRUAL CYCLE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOMICS; RNA SYNTHESIS; TWO DIMENSIONAL ELECTROPHORESIS;

ENDOMETRIUM; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; LUTEAL PHASE; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 77951712400     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900094     Document Type: Article

References (78)

1. Ludwig, H., Spornitz, U.M., Microarchitecture of the human endometrium by scanning electron microscopy: Menstrual desquamation and remodeling. Ann. NY Acad. Sci. 1991, 622, 28-46.
2. Salamonsen, L.A., Jones, R.L., in: Henry, H.L., Norman, A.W. (Eds.), Encyclopedia of Hormones. Academic Press, San Diego 2003, pp. 504-512.
3. Salamonsen, L.A., in: Aplin, J., Fazleabas, A., Glasser, R., Giudice, L. (2nd Eds.), Endometrium: Molecular, Cellular and Clinical Perspectives. Informa UK Ltd, London 2007, pp 25-45.
4. Torres, P., Florio, P., Galleri, L., Reis, F.M. et al., Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis. Reprod. Sci. 2009, 16, 727-733.
5. Fowler, P.A., Tattum, J., Bhattacharya, S., Klonisch, T. et al., An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: A heterogeneous tissue with a complex disease. Proteomics 2007, 7, 130-142.
6. Have, S.T., Fraser, I., Markham, R., Lam, A., Matsumoto, I., Proteomic analysis of protein expression in the eutopic endometrium of women with endometrios. Proteomics Clin. Appl. 2007, 1, 1243-1251.
7. Burney, R.O., Talbi, S., Hamilton, A.E., Vo, K.C. et al., Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007, 148, 3814-3826.
8. Kao, L.C., Germeyer, A., Tulac, S., Lobo, S. et al., Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144, 2870-2881.
9. Vinatier, D., Cosson, M., Dufour, P., Is endometriosis an endometrial disease? Eur. J. Obstet. Gynecol. Reprod. Biol. 2000, 91, 113-125.
10. Healy, D.L., Rogers, P., Hii, L., Wingfield, M., Angiongenesis: A new theory for endometriosis. Hum. Reprod. Update 1998, 4, 736-740.
11. Liao, X., Siu, M.K., Au, C.W., Chan, Q.K. et al., Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin. Mod. Pathol. 2009, 22, 839-847.
12. Jeong, J.W., Lee, H.S., Franco, H.L., Broaddus, R.R. et al., Beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 2009, 28, 31-40.
13. Dubé, V., Grigull, J., DeSouza, L.V., Ghanny, S. et al., Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format. J. Proteome Res. 2007, 6, 2648-2655.
14. Yoshizaki, T., Enomoto, T., Nakashima, R., Ueda, Y. et al., Altered protein expression in endometrial carcinogenesis. Cancer Lett. 2005, 226, 101-106.
15. Sen, S., Chowdhury, G., Chowdhury, M., Sialic acid binding protein of human endometrium: Its regulation by steroids. Mol. Cell Biochem. 2001, 221, 17-23.
16. Vigne, J.L., Hornung, D., Mueller, M.D., Taylor, R.N., Purification and characterization of an immunomodulatory endometrial protein, glycodelin. J. Biol. Chem. 2001, 276, 17101-17105.
17. Seppälä, M., Yajima, M., Koistinen, R., Angervo, M. et al., Endometrial proteins as local regulators of human endometrial function and their appearance in serum: Clinical applications. Ann. NY Acad. Sci. 1991, 626, 312-320.
18. Seppala, M., Riittinen, L., Kamarainen, M., Julkunen, M., A review of endometrial protein PP14 secretion during the postovulatory period and pregnancy. Reprod. Fertil. Dev. 1992, 4, 611-618.
19. Sarkar, M.A., Vadlamuri, V., Ghosh, S., Glover, D.D., Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle. Drug. Metab. Dispos. 2003, 31, 1-6.
20. Talbi, S., Hamilton, A.E., Vo, K.C., Tulac, S. et al., Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006, 147, 1097-1121.
21. Kao, L.C., Tulac, S., Lobo, S., Imani, B. et al., Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002, 143, 2119-2138.
22. DeSouza, L., Diehl, G., Yang, E.C., Guo, J. et al., Proteomic analysis of the proliferative and secretory phases of the human endometrium: Protein identification and differential protein expression. Proteomics 2005, 5, 270-281.
23. Chen, J., Hannan, N., Mak, Y., Nicholls, P. et al., Proteomic characterization of midproliferative and midsecretory human endometrium. J. Proteome Res. 2009, 8, 2032-2044.
24. Noyes, R.W., Hertig, A.T., Rock, J., Dating the endometrial biopsy. Am. J. Obstet. Gynecol. 1975, 122, 262-263.
25. Henkel, A.W., Bieger, S.C., Quantification of proteins dissolved in an electrophoresis sample buffer. Anal. Biochem. 1994, 223, 329-331.
26. Anderson, N.L., Esquer-Blasco, R., Hofmann, J.P., Anderson, N.G., A two-dimensional gel database of rat liver proteins useful in gene regulation and drug effect studies. Electrophoresis 1991, 12, 907-930.
27. Ace, C.I., Okulicz, W.C., Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod. Biol. Endocrinol. 2004, 2, 54.
28. Tang, P.Z., Gannon, M.J., Andrew, A., Miller, D., Evidence for oestrogenic regulation of heat shock protein expression in human endometrium and steroid-responsive cell lines. Eur. J. Endocrinol. 1995, 133, 598-605.
29. Tsuchiya, Y., Nakajima, M., Kyo, S., Kanaya, T. et al., Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res. 2004, 64, 3119-3125.
30. Kodama, A., Lechler, T., Fuchs, E., Coordinating cytoskeletal tracks to polarize cellular movements. J. Cell Biol. 2004, 167, 203-207.
31. Schroer, T.A., Dynactin. Annu. Rev. Cell Dev. Biol. 2004, 20, 759-779.
32. Ziegler, W.H., Liddington, R.C., Critchley, D.R., The structure and regulation of vinculin. Trends Cell Biol. 2006, 16, 453-460.
33. Kim, K., McCully, M.E., Bhattacharya, N., Butler, B. et al., Structure/function analysis of the interaction of phosphatidylinositol 4,5-bisphosphate with actin-capping protein: Implications for how capping protein binds the actin filament. J. Biol. Chem. 2007, 282, 5871-5879.
34. Tsakiridis, T., Tong, P., Matthews, B., Tsiani, E. et al., Role of the actin cytoskeleton in insulin action. Microsc. Res. Tech. 1999, 47, 79-92.
35. Atencia, R., Asumendi, A., Garcia-Sanz, M., Role of cytoskeleton in apoptosis. Vitam. Horm. 2000, 58, 267-297.
36. Izawa, I., Inagaki, M., Regulatory mechanisms and functions of intermediate filaments: A study using site-and phosphorylation state-specific antibodies. Cancer Sci. 2006, 97, 167-174.
37. Welch, W.J., The mammalian heat shock (or stress) response: A cellular defense mechanism. Adv. Exp. Med. Biol. 1987, 225, 287-304.
38. Pratt, W.B., The hsp90-based chaperone system: Involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med. 1998, 217, 420-434.
39. Buchner, J., Hsp90 & Co. - a holding for folding. Trends Biochem. Sci. 1999, 24, 136-141.
40. Shyamala, G., Gauthier, Y., Moore, S.K., Catelli, M.G., Ullrich, S.J., Estrogenic regulation of murine uterine 90-kilodalton heat shock protein gene expression. Mol. Cell Biol. 1989, 9, 3567-3570.
41. Wu, W.X., Derks, J.B., Zhang, Q., Nathanielsz, P.W., Changes in heat shock protein-90 and -70 messenger ribonucleic acid in uterine tissues of the ewe in relation to parturition and regulation by estradiol and progesterone. Endocrinology 1996, 137, 5685-5693.
42. Rivera-Gonzalez, R., Petersen, D.N., Tkalcevic, G., Thompson, D.D., Brown, T.A., Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen. J. Steroid Biochem. Mol. Biol. 1998, 64, 13-24.
43. Wataba, K., Saito, T., Fukunaka, K., Ashihara, K. et al., Overexpression of heat shock proteins in carcinogenic endometrium. Int. J. Cancer 2001, 91, 448-456.
44. Jessop, C.E., Chakravarthi, S., Watkins, R.H., Bulleid, N.J., Oxidative protein folding in the mammalian endoplasmic reticulum. Biochem. Soc. Trans. 2004, 32, 655-658.
45. Ellgaard, L., Ruddock, L.W., The human protein disulphide isomerase family: Substrate interactions and functional properties. EMBO Rep. 2005, 6, 28-32.
46. Mori, H., Kamada, M., Maegawa, M., Yamamoto, S. et al., Enzymatic activation of immunoglobulin binding factor in female reproductive tract. Biochem. Biophys. Res. Commun. 1998, 246, 409-413.
47. Huber, R., Berendes, R., Burger, A., Schneider, M. et al., Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. J. Mol. Biol. 1992, 223, 683-704.
48. Demange, P., Voges, D., Benz, J., Liemann, S. et al., Annexin V: The key to understanding ion selectivity and voltage regulation? Trends Biochem. Sci. 1994, 19, 272-276.
49. Raynal, P., Hullin, F., Ragab-Thomas, J.M.F., Fauvel, J., Chap, H., Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells. Biochem. J. 1993, 292, 759-766.
50. Rothhut, B., Dubois, T., Feliors, D., Russo-Marie, F., Oudinet, J.P., Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur. J. Biochem. 1995, 232, 865-872.
51. Wallner, B.P., Mattaliano, R.J., Hession, C., Cate, R.L., Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 1986, 320, 77-81.
52. Iwasaki, A., Suda, M., Nakao, H., Nagoya, T. et al., Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: A new lipocortin-like protein. J. Biochem. 1987,102, 1261-1273.
53. Learmonth, M.P., Howell, S.A., Harris, A.C., Amess, B. et al., Novel isoforms of CaBP 33/37 (annexin V) from mammalian brain: Structural and phosphorylation differences that suggest distinct biological roles. Biochim. Biophys. Acta 1992, 1160, 76-83.
54. Mosesson, M.W., Fibrinogen gamma chain functions. J. Thromb. Haemost. 2003, 1, 231-238.
55. Everse, S.J., New insights into fibrin (ogen) structure and function. Vox. Sang. 2002, 83, 375-382.
56. Apte, S.P., in: Sarangarajan, R. (Ed.), Cellular Respiration and Carcinogenesis, Humana Press, LLC 2009, pp. 103-118.
57. Chang, H.C., Rubin, G.M., 14-3-3 epsilon positively regulates Ras-mediated signaling in Drosophila. Genes Dev. 1997, 11, 1132-1139.
58. Craparo, A., Freund, R., Gustafson, T.A., 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J. Biol. Chem. 1997, 272, 11663-11669.
59. Abbondanza, C., Rossi, V., Roscigno, A., Gallo, L. et al., Interaction of Vault particles with estrogen receptor in the MCF-7 breast cancer cell. J. Cell Biol. 1998, 141, 1301-1310.
60. Kim, E., Lee, S., Mian, M.F., Yun, S.U. et al., Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signaling. FEBS J. 2006, 273, 793-804.
61. Ryu, S.J., An, H.J., Oh, Y.S., Choi, H.R. et al., On the role of major vault protein in the resistance of senescent human diploid broblasts to apoptosis. Cell Death Differ. 2008, 15, 1673-1680.
62. Zerial, M., McBride, H., Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001, 2, 107-117.
63. Chia, W.J., Tang, B.L., Emerging roles for Rab family GTPases in human cancer. Biochim. Biophys. Acta 2009, 1795, 110-116.
64. Wilson, G.M., Fielding, A.B., Simon, G.C., Yu, X. et al., The FIP3-Rab11 protein complex regulates recycling endosome targeting to the cleavage furrow during late cytokinesis. Mol. Biol. Cell 2005, 16, 849-860.
65. Miserey-Lenkei, S., Couëdel-Courteille, A., Del Nery, E., Bardin, S. et al., A role for the Rab6A' GTPase in the inactivation of the Mad2-spindle checkpoint. EMBO J. 2006, 25, 278-289.
66. Gerke, V., Moss, S.E., Annexins and membrane dynamics. Biochim. Biophys. Acta 1997, 1357, 129-154.
67. Powers, C.A., Mathur, M., Raaka, B.M., Ron, D., Samuels, H.H., TLS (translocated-in-liposarcoma) is a high-afnity interactor for steroid, thyroid hormone, and retinoid receptors. Mol. Endocrinol. 1998, 12, 4-18.
68. Arao, Y., Kikuchi, A., Ikeda, K., Nomoto, S. et al., A1U-richelement RNA-binding factor 1/heterogeneous nuclear ribonucleoprotein D gene expression is regulated by oestrogen in the rat uterus. Biochem. J. 2002, 361, 125-132.
69. Auboeuf, D., Honig, A., Berget, S.M., O'Malley, B.W., Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002, 298, 416-419.
70. Piñol-Roma, S., Dreyfuss, G., Cell cycle-regulated phosphorylation of the pre-mRNA-binding (heterogeneous nuclear ribonucleoprotein) C proteins. Mol. Cell Biol. 1993, 13, 5762-5770.
71. Kim, J.H., Paek, K.Y., Choi, K., Kim, T.D. et al., Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell Biol. 2003, 23, 708-720.
72. Hsu, C.Y., Yung, B.Y., Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int. J. Cancer 2000, 88, 392-400.
73. Gu, Z., Lee, R.Y., Skaar, T.C., Bouker, K.B. et al., Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780). Cancer Res. 2002, 62, 3428-3437.
74. Koike, H., Karas, R.H., Baur, W.E., O'DonnellJr, T.F. Mendelsohn, M.E., Differential-display polymerase chain reaction identies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells. J. Vasc. Surg. 1996, 23, 477-482.
75. Skaar, T.C., Prasad, S.C., Sharareh, S., Lippman, M.E. et al., Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 1998, 67, 391-402.
76. Vergnes, L., Péterfy, M., Bergo, M.O., Young, S.G., Reue, K., Lamin B1 is required for mouse development and nuclear integrity. Proc. Natl. Acad. Sci. USA 2004, 101, 10428-10433.
77. Takamori, Y., Tamura, Y., Kataoka, Y., Cui, Y. et al., Differential expression of nuclear lamin, the major component of nuclear lamina, during neurogenesis in two germinal regions of adult rat brain. Eur. J. Neurosci. 2007, 25, 1653-1662.
78. Fiume, R., Ramazzotti, G., Teti, G., Chiarini, F. et al., Involvement of nuclear PLC 1 in lamin B1 phosphorylation and G2/M cell cycle progression. FASEB J. 2009, 23, 957-966.